Global Hyperbilirubinemia Treatment Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperbilirubinemia Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Phototherapy
1.2.3 Exchange Transfusion
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hyperbilirubinemia Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperbilirubinemia Treatment Market Perspective (2018-2029)
2.2 Global Hyperbilirubinemia Treatment Growth Trends by Region
2.2.1 Hyperbilirubinemia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hyperbilirubinemia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Hyperbilirubinemia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Hyperbilirubinemia Treatment Market Dynamics
2.3.1 Hyperbilirubinemia Treatment Industry Trends
2.3.2 Hyperbilirubinemia Treatment Market Drivers
2.3.3 Hyperbilirubinemia Treatment Market Challenges
2.3.4 Hyperbilirubinemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hyperbilirubinemia Treatment by Players
3.1.1 Global Hyperbilirubinemia Treatment Revenue by Players (2018-2023)
3.1.2 Global Hyperbilirubinemia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hyperbilirubinemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hyperbilirubinemia Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hyperbilirubinemia Treatment Market Concentration Ratio
3.4.1 Global Hyperbilirubinemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperbilirubinemia Treatment Revenue in 2022
3.5 Global Key Players of Hyperbilirubinemia Treatment Head office and Area Served
3.6 Global Key Players of Hyperbilirubinemia Treatment, Product and Application
3.7 Global Key Players of Hyperbilirubinemia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperbilirubinemia Treatment Breakdown Data by Type
4.1 Global Hyperbilirubinemia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Hyperbilirubinemia Treatment Forecasted Market Size by Type (2024-2029)
5 Hyperbilirubinemia Treatment Breakdown Data by Application
5.1 Global Hyperbilirubinemia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Hyperbilirubinemia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hyperbilirubinemia Treatment Market Size (2018-2029)
6.2 North America Hyperbilirubinemia Treatment Market Size by Type
6.2.1 North America Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
6.2.2 North America Hyperbilirubinemia Treatment Market Size by Type (2024-2029)
6.2.3 North America Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
6.3 North America Hyperbilirubinemia Treatment Market Size by Application
6.3.1 North America Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
6.3.2 North America Hyperbilirubinemia Treatment Market Size by Application (2024-2029)
6.3.3 North America Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
6.4 North America Hyperbilirubinemia Treatment Market Size by Country
6.4.1 North America Hyperbilirubinemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hyperbilirubinemia Treatment Market Size by Country (2018-2023)
6.4.3 North America Hyperbilirubinemia Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hyperbilirubinemia Treatment Market Size (2018-2029)
7.2 Europe Hyperbilirubinemia Treatment Market Size by Type
7.2.1 Europe Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
7.2.2 Europe Hyperbilirubinemia Treatment Market Size by Type (2024-2029)
7.2.3 Europe Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
7.3 Europe Hyperbilirubinemia Treatment Market Size by Application
7.3.1 Europe Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
7.3.2 Europe Hyperbilirubinemia Treatment Market Size by Application (2024-2029)
7.3.3 Europe Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
7.4 Europe Hyperbilirubinemia Treatment Market Size by Country
7.4.1 Europe Hyperbilirubinemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hyperbilirubinemia Treatment Market Size by Country (2018-2023)
7.4.3 Europe Hyperbilirubinemia Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hyperbilirubinemia Treatment Market Size (2018-2029)
8.2 China Hyperbilirubinemia Treatment Market Size by Type
8.2.1 China Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
8.2.2 China Hyperbilirubinemia Treatment Market Size by Type (2024-2029)
8.2.3 China Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
8.3 China Hyperbilirubinemia Treatment Market Size by Application
8.3.1 China Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
8.3.2 China Hyperbilirubinemia Treatment Market Size by Application (2024-2029)
8.3.3 China Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hyperbilirubinemia Treatment Market Size (2018-2029)
9.2 Asia Hyperbilirubinemia Treatment Market Size by Type
9.2.1 Asia Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
9.2.2 Asia Hyperbilirubinemia Treatment Market Size by Type (2024-2029)
9.2.3 Asia Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
9.3 Asia Hyperbilirubinemia Treatment Market Size by Application
9.3.1 Asia Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
9.3.2 Asia Hyperbilirubinemia Treatment Market Size by Application (2024-2029)
9.3.3 Asia Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
9.4 Asia Hyperbilirubinemia Treatment Market Size by Region
9.4.1 Asia Hyperbilirubinemia Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hyperbilirubinemia Treatment Market Size by Region (2018-2023)
9.4.3 Asia Hyperbilirubinemia Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Details
11.1.2 Philips Business Overview
11.1.3 Philips Hyperbilirubinemia Treatment Introduction
11.1.4 Philips Revenue in Hyperbilirubinemia Treatment Business (2018-2023)
11.1.5 Philips Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Hyperbilirubinemia Treatment Introduction
11.2.4 GE Healthcare Revenue in Hyperbilirubinemia Treatment Business (2018-2023)
11.2.5 GE Healthcare Recent Developments
11.3 Nice Neotech
11.3.1 Nice Neotech Company Details
11.3.2 Nice Neotech Business Overview
11.3.3 Nice Neotech Hyperbilirubinemia Treatment Introduction
11.3.4 Nice Neotech Revenue in Hyperbilirubinemia Treatment Business (2018-2023)
11.3.5 Nice Neotech Recent Developments
11.4 Getinge Group
11.4.1 Getinge Group Company Details
11.4.2 Getinge Group Business Overview
11.4.3 Getinge Group Hyperbilirubinemia Treatment Introduction
11.4.4 Getinge Group Revenue in Hyperbilirubinemia Treatment Business (2018-2023)
11.4.5 Getinge Group Recent Developments
11.5 Solarc Systems, Inc.
11.5.1 Solarc Systems, Inc. Company Details
11.5.2 Solarc Systems, Inc. Business Overview
11.5.3 Solarc Systems, Inc. Hyperbilirubinemia Treatment Introduction
11.5.4 Solarc Systems, Inc. Revenue in Hyperbilirubinemia Treatment Business (2018-2023)
11.5.5 Solarc Systems, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Hyperbilirubinemia Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Phototherapy
Table 3. Key Players of Exchange Transfusion
Table 4. Key Players of Others
Table 5. Global Hyperbilirubinemia Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Hyperbilirubinemia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Hyperbilirubinemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hyperbilirubinemia Treatment Market Share by Region (2018-2023)
Table 9. Global Hyperbilirubinemia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Hyperbilirubinemia Treatment Market Share by Region (2024-2029)
Table 11. Hyperbilirubinemia Treatment Market Trends
Table 12. Hyperbilirubinemia Treatment Market Drivers
Table 13. Hyperbilirubinemia Treatment Market Challenges
Table 14. Hyperbilirubinemia Treatment Market Restraints
Table 15. Global Hyperbilirubinemia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hyperbilirubinemia Treatment Revenue Share by Players (2018-2023)
Table 17. Global Top Hyperbilirubinemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperbilirubinemia Treatment as of 2022)
Table 18. Global Hyperbilirubinemia Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Hyperbilirubinemia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Hyperbilirubinemia Treatment, Headquarters and Area Served
Table 21. Global Key Players of Hyperbilirubinemia Treatment, Product and Application
Table 22. Global Key Players of Hyperbilirubinemia Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hyperbilirubinemia Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Hyperbilirubinemia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Hyperbilirubinemia Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hyperbilirubinemia Treatment Revenue Share by Application (2018-2023)
Table 30. Global Hyperbilirubinemia Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Hyperbilirubinemia Treatment Revenue Share by Application (2024-2029)
Table 32. North America Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Hyperbilirubinemia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Hyperbilirubinemia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Hyperbilirubinemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Hyperbilirubinemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Hyperbilirubinemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Hyperbilirubinemia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Hyperbilirubinemia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Hyperbilirubinemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Hyperbilirubinemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Hyperbilirubinemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Hyperbilirubinemia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Hyperbilirubinemia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Hyperbilirubinemia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Hyperbilirubinemia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Hyperbilirubinemia Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Hyperbilirubinemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Hyperbilirubinemia Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 64. Philips Company Details
Table 65. Philips Business Overview
Table 66. Philips Hyperbilirubinemia Treatment Product
Table 67. Philips Revenue in Hyperbilirubinemia Treatment Business (2018-2023) & (US$ Million)
Table 68. Philips Recent Developments
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Hyperbilirubinemia Treatment Product
Table 72. GE Healthcare Revenue in Hyperbilirubinemia Treatment Business (2018-2023) & (US$ Million)
Table 73. GE Healthcare Recent Developments
Table 74. Nice Neotech Company Details
Table 75. Nice Neotech Business Overview
Table 76. Nice Neotech Hyperbilirubinemia Treatment Product
Table 77. Nice Neotech Revenue in Hyperbilirubinemia Treatment Business (2018-2023) & (US$ Million)
Table 78. Nice Neotech Recent Developments
Table 79. Getinge Group Company Details
Table 80. Getinge Group Business Overview
Table 81. Getinge Group Hyperbilirubinemia Treatment Product
Table 82. Getinge Group Revenue in Hyperbilirubinemia Treatment Business (2018-2023) & (US$ Million)
Table 83. Getinge Group Recent Developments
Table 84. Solarc Systems, Inc. Company Details
Table 85. Solarc Systems, Inc. Business Overview
Table 86. Solarc Systems, Inc. Hyperbilirubinemia Treatment Product
Table 87. Solarc Systems, Inc. Revenue in Hyperbilirubinemia Treatment Business (2018-2023) & (US$ Million)
Table 88. Solarc Systems, Inc. Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Hyperbilirubinemia Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hyperbilirubinemia Treatment Market Share by Type: 2022 VS 2029
Figure 3. Phototherapy Features
Figure 4. Exchange Transfusion Features
Figure 5. Others Features
Figure 6. Global Hyperbilirubinemia Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Hyperbilirubinemia Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Home Care Case Studies
Figure 11. Hyperbilirubinemia Treatment Report Years Considered
Figure 12. Global Hyperbilirubinemia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Hyperbilirubinemia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Hyperbilirubinemia Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Hyperbilirubinemia Treatment Market Share by Players in 2022
Figure 16. Global Top Hyperbilirubinemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperbilirubinemia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hyperbilirubinemia Treatment Revenue in 2022
Figure 18. North America Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
Figure 20. North America Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
Figure 21. North America Hyperbilirubinemia Treatment Market Share by Country (2018-2029)
Figure 22. United States Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Hyperbilirubinemia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
Figure 26. Europe Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
Figure 27. Europe Hyperbilirubinemia Treatment Market Share by Country (2018-2029)
Figure 28. Germany Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Hyperbilirubinemia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
Figure 36. China Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
Figure 37. Asia Hyperbilirubinemia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
Figure 39. Asia Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
Figure 40. Asia Hyperbilirubinemia Treatment Market Share by Region (2018-2029)
Figure 41. Japan Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Hyperbilirubinemia Treatment Market Share by Country (2018-2029)
Figure 51. Brazil Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Hyperbilirubinemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Philips Revenue Growth Rate in Hyperbilirubinemia Treatment Business (2018-2023)
Figure 58. GE Healthcare Revenue Growth Rate in Hyperbilirubinemia Treatment Business (2018-2023)
Figure 59. Nice Neotech Revenue Growth Rate in Hyperbilirubinemia Treatment Business (2018-2023)
Figure 60. Getinge Group Revenue Growth Rate in Hyperbilirubinemia Treatment Business (2018-2023)
Figure 61. Solarc Systems, Inc. Revenue Growth Rate in Hyperbilirubinemia Treatment Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed